NDC 72888-462 – Oxcarbazepine
Oxcarbazepine 150 mg/1 · Tablet · Oral
Product NDC72888-462
Product details
- Brand name
- Oxcarbazepine
- Generic name
- Oxcarbazepine
- Labeler
- Advagen Pharma Ltd.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA207717
- Marketed since
- May 20, 2025
- Listing expires
- December 31, 2027
- Pharmacologic class
- Anti-epileptic Agent
Active ingredients
- Oxcarbazepine 150 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 72888-462-01 | 100 TABLET in 1 BOTTLE (72888-462-01) | May 20, 2025 |
| 72888-462-02 | 500 TABLET in 1 BOTTLE (72888-462-02) | May 20, 2025 |
Other Oxcarbazepine products
- 72888-460 Oxcarbazepine 300 mg/1 · Tablet · Advagen Pharma Ltd.
- 72888-461 Oxcarbazepine 600 mg/1 · Tablet · Advagen Pharma Ltd.
- 70771-1842 Oxcarbazepine 150 mg/1 · Tablet · Zydus Lifesciences Limited
- 70771-1843 Oxcarbazepine 300 mg/1 · Tablet · Zydus Lifesciences Limited
- 70771-1844 Oxcarbazepine 600 mg/1 · Tablet · Zydus Lifesciences Limited
- 68382-692 Oxcarbazepine 300 mg/1 · Tablet · Zydus Pharmaceuticals (USA) Inc.
- 68382-693 Oxcarbazepine 600 mg/1 · Tablet · Zydus Pharmaceuticals (USA) Inc.
- 68382-691 Oxcarbazepine 150 mg/1 · Tablet · Zydus Pharmaceuticals (USA) Inc.
- 72888-087 Oxcarbazepine 150 mg/1 · Tablet, Film Coated · Advagen Pharma Limited
- 72888-088 Oxcarbazepine 300 mg/1 · Tablet, Film Coated · Advagen Pharma Limited
- 72888-089 Oxcarbazepine 600 mg/1 · Tablet, Film Coated · Advagen Pharma Limited
- 72888-074 Oxcarbazepine 300 mg/5mL · Suspension · Advagen Pharma Ltd